Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7587571 | 0.89 | LMNA (0.46) | LMNABLM | |
| SCHEMBL27336795 | 0.86 | LMNA (0.44) | LMNAKISS1RBLM | |
| SCHEMBL172994 | 0.82 | — | — | |
| SCHEMBL24175702 | 0.80 | LMNA (0.43) | LMNA | |
| SCHEMBL9298695 | 0.80 | KISS1R (0.41) | LMNAKISS1RHTR2AHRH1EPHX1 | |
| SCHEMBL21982018 | 0.79 | CA12 (0.48) | LMNAPAOX | |
| SCHEMBL19540085 | 0.78 | MEN1 (0.34) | HTR2AHRH1 | |
| SCHEMBL26800526 | 0.78 | KISS1R (0.30) | KISS1R | |
| SCHEMBL22662445 | 0.78 | LMNA (0.48) | LMNAKISS1RHTR2AHRH1BLM | |
| SCHEMBL23542907 | 0.78 | KISS1R (0.39) | LMNAKISS1RHTR2AHRH1PAOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230293706-A1 | Multicomponent Delivery Systems for Polyanionic Cargo Compound Delivery | MEDICI THERAPEUTICS, INC. | 2023-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230293706-A1 | Multicomponent Delivery Systems for Polyanionic Cargo Compound Delivery | MTREX, EXOSC5, KPNA6 | LMNA 474/4885KISS1R 3610/4885HTR2A 3427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.